Table 1 Weighted baseline characteristics of study population

From: Predictive role of the dietary inflammatory index on stroke risk among hypertensive patients

Characteristics

Overall

(n = 23,712)

Non-stroke

(n = 21,842)

Stroke

(n = 1870)

P value

Age, years

57.16 ± 0.21

56.55 ± 0.21

66.35 ± 0.44

 < 0.0001

Sex, n (%)

   

 < 0.001

 Female

12,068 (50.82)

11,118 (50.47)

950 (55.97)

 

 Male

11,644 (49.18)

10,724 (49.53)

920 (44.03)

 

Race, n (%)

   

 < 0.001

 Mexican American

3129 (5.51)

2949 (5.58)

180 (4.48)

 

 Non-Hispanic Black

6354 (13.77)

5794 (13.53)

560 (17.35)

 

 Non-Hispanic White

10,632 (69.78)

9744 (69.91)

888 (67.84)

 

 Other Race

3597 (10.94)

3355 (10.98)

242 (10.33)

 

Education level, n (%)

   

 < 0.0001

 High school or above

16,873 (80.79)

15,654 (81.31)

1219 (72.94)

 

 Less than High School

6839 (19.21)

6188 (18.69)

651 (27.06)

 

Marital status, n (%)

   

 < 0.0001

 Married

10,677 (50.89)

9950 (51.38)

727 (43.61)

 

 Other

13,035 (49.11)

11,892 (48.62)

1143 (56.39)

 

Smoking, n (%)

   

 < 0.001

 Never

11,881 (49.41)

11,116 (49.85)

765 (42.90)

 

 Former

7432 (31.62)

6727 (31.40)

705 (34.99)

 

 Now

4399 (18.96)

3999 (18.75)

400 (22.11)

 

Alcohol use, n (%)

   

 < 0.0001

 Never

3715 (12.74)

3384 (12.36)

331 (18.42)

 

 Former

4923 (18.26)

4360 (17.62)

563 (27.78)

 

 Mild

8417 (37.54)

7834 (37.84)

583 (33.02)

 

 Moderate

3057 (14.64)

2867 (14.93)

190 (10.33)

 

 Heavy

3600 (16.82)

3397 (17.25)

203 (10.45)

 

PIR

2.93 ± 0.03

2.97 ± 0.03

2.29 ± 0.06

 < 0.0001

BMI, kg/m2

30.85 ± 0.08

30.88 ± 0.08

30.49 ± 0.23

0.11

eGFR, mL/min/1.73m2

84.27 ± 0.29

85.24 ± 0.29

69.86 ± 0.75

 < 0.0001

FPG, mg/dL

115.31 ± 0.35

114.77 ± 0.35

123.37 ± 1.73

 < 0.0001

ALT, U/L

26.28 ± 0.21

26.57 ± 0.23

22.02 ± 0.36

 < 0.0001

AST, U/L

25.97 ± 0.14

26.11 ± 0.15

23.94 ± 0.30

 < 0.0001

SCR, mg/dL

0.95 ± 0.00

0.94 ± 0.00

1.11 ± 0.02

 < 0.0001

TG, mg/dL

203.50 ± 1.89

204.44 ± 1.96

189.43 ± 5.81

0.01

TC, mg/dL

199.13 ± 0.49

199.89 ± 0.50

187.82 ± 1.66

 < 0.0001

HDL-C, mg/dL

52.29 ± 0.18

52.40 ± 0.18

50.70 ± 0.55

0.002

LDL-C, mg/dL

106.59 ± 0.39

107.05 ± 0.40

99.67 ± 1.36

 < 0.0001

DII

1.51 ± 0.02

1.48 ± 0.02

1.97 ± 0.06

 < 0.0001

DM, n (%)

   

 < 0.0001

 No

16,584 (75.21)

15,517 (76.35)

1067 (58.25)

 

 Yes

7128 (24.79)

6325 (23.65)

803 (41.75)

 

CHD, n (%)

   

 < 0.0001

 No

21,818 (92.52)

20,302 (93.47)

1516 (78.43)

 

Yes

1894 (7.48)

1540 (6.53)

354 (21.57)

 

Antihypertensive drugs, n (%)

   

 < 0.0001

 No

8244 (38.01)

7949 (39.53)

295 (15.52)

 

 Yes

15,468 (61.99)

13,893 (60.47)

1575 (84.48)

 

Hypoglycemic agents, n (%)

   

 < 0.0001

 No

18,963 (83.81)

17,660 (84.69)

1303 (70.72)

 

 Yes

4749 (16.19)

4182 (15.31)

567 (29.28)

 

Lipid lowering drugs, n (%)

   

 < 0.0001

 No

15,874 (68.03)

15,024 (69.70)

850 (43.15)

 

 Yes

7838 (31.97)

6818 (30.30)

1020 (56.85)

 

Antiplatelet drugs, n (%)

   

 < 0.0001

 No

22,292 (95.15)

20,869 (96.47)

1221 (65.29)

 

 Yes

1420 (4.85)

973 (3.53)

649 (34.71)

 
  1. Continuous measures are presented as mean ± standard deviation (SD)
  2. Categorical variables are presented as weighted percentages
  3. PIR, Poverty Income Ratio; BMI, Body Mass Index; eGFR, Estimated Glomerular Filtration Rate; FPG, Fasting Plasma Glucose; ALT, Alanine Aminotransferase; AST, Aspartate Aminotransferase; SCR, Serum Creatinine; TG, Triglycerides; TC, Total Cholesterol; HDL-C, High-Density Lipoprotein Cholesterol; LDL-C, Low-Density Lipoprotein Cholesterol; DII, Dietary Inflammatory Index; DM, Diabetes Mellitus; CHD, Coronary Heart Disease